Chemistry Ventures Targets $500M Second Fund to Back Early-Stage Tech Startups

Chemistry Ventures is raising US$500 million for its second fund according to recent reports and filings.

The move comes just two years after the firm launched with a debut fund of around US$350 million.

Why This Fundraising Matters for Startups

Founders Mark Goldberg, Ethan Kurzweil, and Kristina Shen launched Chemistry after building their careers at Bessemer Venture Partners, Index Ventures, and Andreessen Horowitz to focus on early-stage opportunities.

They plan to invest in areas such as developer tools, fintech, and infrastructure while moving quickly to support founders.

This larger second fund shows strong backing from investors who see potential in the team's approach.

What It Means for the Future of Venture Capital

The fundraising highlights continued investor confidence in early-stage investing even as markets face ups and downs.

More capital like this could help promising startups expand faster and bring new technologies to market.

Over time it may encourage other firms to raise bigger pools for similar bets on innovation.

For everyday people this activity often leads to better apps, services, and technologies that improve daily life.

Looking ahead, Chemistry aims to out-hustle bigger players by staying agile and founder-focused.

The story reflects continued investor appetite for supporting fresh ideas in a competitive venture capital landscape.